Agilisium Plans To Shift Asia Headquarters To Hyderabad
“India has proven its ability to build globally competitive technology businesses. The next opportunity is to combine this strength with scientific expertise, deep industry knowledge and proprietary IP to transform global industries,” said Raj Babu, founder and CEO, Agilisium.
Hyderabad: Agilisium, a life sciences company, announced plans to shift its Asia headquarters to Hyderabad. The move recognises Telangana’s growing prominence in the global life sciences sector.
“India has proven its ability to build globally competitive technology businesses. The next opportunity is to combine this strength with scientific expertise, deep industry knowledge and proprietary IP to transform global industries,” said Raj Babu, founder and CEO, Agilisium.
“AI in Life Sciences depends on bringing together scientific expertise, deep domain context and intelligent technology to solve complex industry challenges. At Agilisium, we are investing in talent, proprietary AI platforms and delivery models. The planned relocation of our Asia headquarters to Hyderabad strengthens our commitment to building differentiated intellectual property and delivering measurable business value,” said Arun Kumar, chief operating officer and chief AI and innovation officer, Agilisium.
Since entering the life sciences sector in 2018, Agilisium has built capabilities across research and drug discovery, clinical development, manufacturing and commercial operations. The company is on track to close 2026 with revenue of $72 - $75 million, the company said in a release.